ImmunoPrecise Antibodies Ltd. filed a Form 6-K on April 9, 2025, incorporating various press releases from earlier this year dated February 26 and February 20, along with prior announcements from December 2024. This filing is significant as it keeps investors informed about the company's recent developments and ongoing status.